Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BDNF shows potential for stroke therapy in rat model

July 18, 1997

MS&D continues to pursue antimigraine agents

July 18, 1997

Promising preliminary results reported for Interneuron's ischemic stroke treatment

July 17, 1997

FDA approves first medical device for epilepsy

July 17, 1997

Acetylcholine receptor modulators reported by SIBIA Neurosciences

July 17, 1997

Biomedica Foscama discloses adenosine antagonists for depression

July 17, 1997

Merck Sharp & Dohme reveals new tachykinin antagonists

July 17, 1997

Future therapeutic targets for AD

July 17, 1997

Long-acting benzodiazepines increase risk of car crashes in the elderly

July 16, 1997

RiboGene signs marketing agreement for intranasal metoclopramide

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...